A receptor tyrosine kinase (RTK), TIE (tyrosine kinase that contains immunoglobulin-like loops and epidermal growth factor [EGF] homology domains), is expressed in vascular endothelial and hematopoietic cells. We generated monoclonal antibodies (MoAbs) against the extracellular domain of TIE and a polyclonal antibody against the TIE carboxyterminus and used them t o analyze expression of TIE in hematopoietic cells. Western blotting detected two forms of TIE protein with a molecular mass of 135 and 130 kD in hematopoietic and endothelial cells. Northern blotting analysis revealed that TIE was expressed preferentially in undifferentiated cell lines, especially when megakaryocytic, but not erythroid differentiation was induced. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed that TIE was predominantly expressed in the human hematopoi-ROLIFERATION and differentiation of hematopoietic
A receptor tyrosine kinase (RTK), TIE (tyrosine kinase that contains immunoglobulin-like loops and epidermal growth factor [EGF] homology domains), is expressed in vascular endothelial and hematopoietic cells. We generated monoclonal antibodies (MoAbs) against the extracellular domain of TIE and a polyclonal antibody against the TIE carboxyterminus and used them t o analyze expression of TIE in hematopoietic cells. Western blotting detected two forms of TIE protein with a molecular mass of 135 and 130 kD in hematopoietic and endothelial cells. Northern blotting analysis revealed that TIE was expressed preferentially in undifferentiated cell lines, especially when megakaryocytic, but not erythroid differentiation was induced. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed that TIE was predominantly expressed in the human hematopoi-ROLIFERATION and differentiation of hematopoietic The TIE gene is a RTK gene that was first isolated from the K562 chronic myeloid leukemia cell line.5 TIE has two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains, and three fibronectin type 111-like repeats in the extracellular region and a kinase domain with a short kinase insert sequence in the intracellular region5 These structural properties are shared by TEK, and these two receptors constitute a distinct subfamily of RTKs.~,' TIE and TEK are broadly expressed in endothelial Targeted mutations of these two genes in mice demonstrated that they have important but distinct roles in the formation of blood vessel^.^^'" However, because both mutant mice are embryonic lethal, the involvement of TIE and TEK in hematopoiesis has not been well evaluated.
TIE is expressed in some myeloid cell lines, and its expression is upregulated when megakaryocytic differentiation is i n d~c e d .~ We cloned cDNA for mouse TIE and TEK genes, and demonstrated their mRNA expression in hematopoietic progenitor cells. 6 In addition, we isolated the human TIE gene, and its mRNA was also expressed predominantly in CD34+ progenitor cells. To identify precisely the nature of TIE expression in hematopoietic cells, we established monoclonal antibodies (MoAbs) against human TIE and characterized the functions of sorted TIE-positive (TIE+) cells. (FACS) showed that 42% of CD34+ and 17% of KIT-positive (KIT') cells were TIE-positive (TIE'). The majority (81%) of the primitive hematopoietic stem cells, CD34+CD38-cells, were TIE+. Assays of progenitor cells and long-term culture-initiating cells (LTC-IC) showed that the TIE+ fraction contained more primitive cells than the TIEfraction. Some TIE+ cells were in the CD34-fraction, which were CD19+ and CD20+ (B cells). These findings indicate that TIE has a unique spectrum of expression in primitive hematopoietic stem cells and B cells. Although its ligand has not been identified, TIE and its ligand may establish a novel regulatory pathway not only in early hematopoiesis, but also in the differentiation and/or proliferation of B cells.
MATERIALS AND METHODS
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Brand Milk Products CO, Tochigi, Japan). Hereafter, UT-7 cells cultured with GM-CSF and UT-7 cells cultured with Epo are referred to as UT-7/GM and UT-7/Epo, respectively. UT-7/GM, CMK,'' K562, HL60, and KMT-2I3 cells were cultured with 10 nmoVL phorbol 12-myristate 13-acetate ([PMA] Sigma Chemical CO, St Louis, MO) for 3 days to induce megakaryocytic differentiation. UT-7Epo cells were cultured with 1.3 mmol/L n-butyric acid (Sigma Chemical CO) for 5 days14 and K562 cells were cultured with 360 nmoVL cytosine arabinoside ([Ara-C] Nippon Shinyaku, Kyoto, Japan) for 5 days to induce erythroid differentiation. Human umbilical vein endothelial cells (Sanko Junyaku CO, Ltd, Tokyo, Japan) were cultured in the presence of endothelial cell growth supplement (Collaborative Biochemical Products, Bedford, MA) and 10% FCS in medium 199 (GIBCO).
Full-length TIE cDNA was inserted into the expression vector pMKITneo and introduced into interleukin-3 (IL-3)-dependent Ba/F3 cells and BALBI 3T3 cells by electroporation. (3418 (Geneticin Disulfate; Wako Pure Chemical Industries, Ltd, Osaka, Japan)-resistant clones were selected (BaF3/TIE cells and 3T3/TIE cells). Ba/F3 cells and BALBI 3T3 cells transfected with vector alone (BaF3Ivector cells and 3T3I vector cells) were also used as negative control cells.
Total RNA was extracted from hematopoietic Establishment of TIE-overexpressing cell lines.
Northern blotting.
cell lines using acid guanidinium thiocyanate-phenol-chloroform, and poly(A)+ RNA was selected using Oligotex-dT30 (Takara Shuzo, Kyoto, Japan). Two micrograms of poly(A)' RNA was loaded onto a formaldehyde gel, which was Northem-blotted as previously de~cribed,'~ using a Zeta-Probe blotting membrane (BioRad, Richmond, CA). Hybridization and washes were performed according to the manufacturer's instructions. The 562-bp BamHIBamHI fragment derived from the extracellular domain of human TIE cDNA was [a-32P]dCTP-labeled using a Megalabel kit (Amersham Japan, Tokyo) and hybridized to the blot. Total RNA was obtained from fractionated cells as previously described.16 The first-strand cDNA was synthesized from the total RNA using a cDNA synthesis system (Bethesda Research Laboratories, Gaithersburg, MD) and random hexamer oligonucleotides. Samples of cDNA representing approximately equivalent cell numbers (5,000) were amplified.
PCR primers for the human TIE gene were directed to amplify a portion of the extracellular domain. Human P-actin was used as a reference gene. Primer sequences were as follows: sense primer, 5 ' -TGG AG AAGGACGACCGTATCGT-3 ' ; antisense primer, 5 ' -TGTAGAAGTAGGATCCGTTG-3'; P-actin sense primer, 5 '-CTG-GAC'ITCGAGCAAGAGAT-3'; and @actin antisense primer, 5'-TCGTCATACTCCTGClTGCT-3'. Ten percent of this reaction mixture was resolved by electrophoresis on a 2% agarose gel and Southem-blotted using a Hybond N plus membrane (Amersham Japan). The membrane was hybridized with [c~-'~P]dCTP-labeied TIE DNA (312 bp) and P-actin DNA (400 bp) fragments, which were amplified by PCR according to the TIE or human P-actin cDNA sequences. The membranes were washed under particularly stringent conditions.
Mouse MoAbs against TIE were prepared as follows. The TIE extracellular domain tagged with the FLAG epitope containing the amino acid sequence, DYKDDDDK, was produced by COS7 cells, and was then purified from the supematants by affinity purification using a monoclonal anti-FLAG antibody column (Kodak, New Haven, CT). A 6-weekold BALB/c mouse purchased from SLC (Hamamatsu, Japan) was immunized intraperitoneally at 2-week intervals with the TIE extracellular domain. Spleen cells were fused with murine myeloma cells (P3-X63-Ag8-U1) using polyethylene glycol 3350 (Sigma Chemical). Hybridoma clones were selected by fluorescence-activated cell sorting (FACS) using BALB13T3 cells and Ba/F3 cells transfected with human TIE cDNA as indicators. Positive clones were further characterized by immunoprecipitation. Antibodies were purified using a protein A-Sepharose column and biotinylated.
Polyclonal antibodies against TIE were raised in rabbits by immunization with a KLH-conjugated synthetic polypeptide corresponding to the C-terminal 15 amino acids of TIE protein. Mouse antiserum against TIE was also obtained from mice immunized with the TIE extracellular domain.
Cells were solubilized with lysis buffer 1% Nonidet P-40, HEPES, pH 7.4, 150 mmol/L NaCI, 1 mmol/L EDTA, 50 pg/mL aprotinin, and 1 mmoVL phenylmethylsulfonyl fluoride (PMSF). The lysates were incubated with a MoAb against TIE overnight at 4°C. Immunocomplexes were collected on protein G-Sepharose (Pharmacia, Uppsala, Sweden), washed three times with lysis buffer, and heated for 3 minutes at I00"C in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer with 5% 2-mercaptoethanol (2-ME). Immunoprecipitates were resolved by SDS-PAGE and transferred to nitrocellulose membranes (Nihon Millipore Ltd, Yonezawa, Japan). The membranes were then probed with the polyclonal antibody, and specific
Reverse transcriptase-polymerase chain reaction (RT-PCR).
Production of MoAbs and polyclonal antibodies.
Immunoprecipitation.
binding was detected using the enhanced chemiluminescence system (Amersham Japan).
In the immunoprecipitation experiment, specific binding of MoAb HT50 to TIE protein in cell lysates was blocked by preincubation with a 20-fold excess molarity of TIE-FLAG fusion protein for 1 hour at 4°C. Immune complexes were collected and Western-blotted as described earlier. In the Western blotting experiment, specific binding of rabbit anti-TIE polyclonal antibody to TIE protein was blocked by preincubation with a 100-fold excess molarity of the TIE C-terminal synthetic peptide that was used for immunization of the rabbits.
BaF3RIE cells, incubated for 12 hours in the absence of IL-3, were solubilized with lysis buffer (50 mmoVL HEPES, pH 7.4, 1% Triton X-100, 10% glycerol, 10 mmol/L sodium pyrophosphate, 100 mmol/L sodium fluoride, 4 mmoUL EDTA, 2 m m o L sodium orthovanadate, 50 pg/ mL aprotinin, 1 mmol/L PMSF, 100 pmol/L leupeptin, and 25 pmol/ L pepstatin A) and TIE was immunoprecipitated with the monoclonal anti-TIE antibody (HT50). Tyrosine phosphorylation of TIE was evaluated by Western blotting with the antiphosphotyrosine antibody, 4G10 (Upstate Biotechnology Inc, Lake Placid, NY). To detect TIE protein, the membrane was stripped and reprobed with rabbit antiserum against TIE.
Bone marrow cells were obtained from normal healthy volunteers who had given informed consent. Cells diluted with phosphate-buffered saline (PBS) were centrifuged over Ficoll-Metrizoate (Ficoll-Paque; Pharmacia) for 30 minutes at 400X g . Mononuclear cells recovered from the interface were suspended in PBS containing 5% FCS and 0.01% sodium azide.
Bone marrow mononuclear cells were stained with biotinylated anti-TIE MoAbs, followed by allophycocyanin-conjugate streptavidin (Becton Dickinson Immunocytometry System, San Jose, CA) with combinations of the following antibodies; fluorescein isothiocyanate (F1TC)-conjugated 4A1 (CD34 MoAb; Nichirei Corp, Tokyo, Japan), FlTC-conjugated NUc-kit (anti-KIT MoAb; Nichirei), phycoerythrin (PE)-conjugated CD38 MoAb (Becton Dickmson), PE-conjugated CD3 MoAb (Nichirei), FITC-conjugated CDI 9 MoAb (DAKO, Glostrup, Denmark), FITC-conjugated CD20 MoAb (Nichirei), or PE-conjugated CD33 MoAb (DAKO). Hematopoietic cell lines were stained with biotinylated anti-TIE MoAbs and FITC-conjugated avidin as described earlier. To clarify the specificity of anti-TIE MoAb, HT50, we preincubated HT50 with a 20-fold excess molarity of human or mouse TIE extracellular protein tagged with human IgGl Fc protein (TIE-IgG protein) for 30 minutes on ice. Then, BaF3RIE cells were stained with pretreated HT50. These cells were suspended in staining solution containing propidium iodide (PI).
Three-color FACS analysis and cell sorting were performed on a FACSvantage (Becton Dickinson) equipped with a 488-nm argon laser and a 632-nm Heme laser as previously de~cribed.'~.'" Compensation was adjusted using mononuclear cells stained with biotinylated HLA-DR and FITC-conjugated streptavidin or PE-conjugated streptavidin for FITC and PE channels. Unstained cells were used as controls. Data from greater than 20,000 bone marrow mononuclear cells were collected, and were analyzed using a computer (Yokogawa-Hewlett-Packard Ltd, Tokyo, Japan) with LYSYS 11 software (Becton Dickinson). Fluorescence intensity of individual cells was measured as relative fluorescence units. Viability of the isolated bone marrow mononuclear cells was usually over 97%. Residual erythrocytes and dead cells were gated out using forward-and sidescatter channels and by PI staining at the time of data analysis and sorting. Forward-and side-scatter sorting gates were set as previously de~cribed.'~.'~
Blocking of speciJic binding of anti-TIE antibodies.
Detection of tyrosine phosphorylation of TIE.
Preparation of human bone marrow cells.
FACS analysis and cell sorring.
For
Progenitor czs.sn.v in meth,vlcellulose crtlture. Sorted cells were plated in methylcellulose medium." Briefly, cells were embedded in I mL 1.2% methylcellulose (1,500 cp: Aldrich Chemical Co. Milwaukee, WI), 30% FCS, 1% deionized bovine serum albumin (Sigma Chemical). 5 X mol/L 2-ME (Sigma Chemical), 2 U/ mL recombinant human Epo. 100 ng/mL stem cell factor (SCF), and I O nglmL IL-3 in IMDM. SCF and IL-3 were provided by Amgen Inc (Thousand Oaks, CA) and Sandoz Pharma Ltd (Basel, Switzerland). respectively. Culture dishes were incubated in a humidified atmosphere at 37°C and 5% CO, for 14 days. The presence of hematopoietic progenitors was then assessed.
Lort~q-terrn cl~ltfire-itlitifltif?~ cellnsscty with strottrctl 1cyr.s. Normal allogeneic stromal layers were prepared in T25 flasks according to the modified method."'." Briefly, 3 X 10' ' bone marrow cells were suspended in 5 mL long-term bone marrow culture (LTRMC) media for stromal layers (IMDM with 12.5% FCS, 12.5% horse serum, 1,Ooo UlmL penicillin, 1 0 0 U/mL streptomycin, 5 X 10" mol/L 2-ME, and 10"' niol/L hydrocortisone [Japan Upjohn. Tokyo]) and cultured for 2 to 5 weeks. When allogeneic stromal cells reached confluence. they were recovered with 0.01% pronase and then subcultured at 3 X 1051mL in 24-well plates (Costar, Cambridge, MA). After again reaching confluence, they were irradiated at 1 0 0 cGyl min to provide a dose of 1,500 cGy. One thousand sorted cells were plated on allogeneic irradiated stromal cell layers in I .5 mL LTBMC media (IMDM with 12.5% FCS, 12.5% horse serum. 2 mmol/L Lglutamine. 1 .
O O O UlmL penicillin, I O 0 UlmL streptomycin, and IO-' mol& hydrocortisone). All LTBMCs were maintained in a humidified atmosphere at 37°C with 5% COz. At weekly intervals, half of the supernatant was removed from the cultures and replaced with fresh medium. Nonadherent cells recovered from the supernatant were returned to each well. Both nonadherent and adherent cells were recovered from selected stromal layers after digestion with 0.01 % pronase, and processed for progenitor assay in methylcellulose culture. 1 (B), KMT-2 (myeloid), and K562 (erythroid), or in the nonhematopoietic cell lines, Hep3B (hepatoma) and MRC-S (fibroblast). Expression of TIE mRNA was significantly increased when undifferentiated cell lines, CMK, UT-7, and K562 cells, were differentiated into megakaryocytic lineage by the addition of PMA (Fig l ) . In contrast, no signal was detected in UT-7/Epo and K562 cells when they were differentiated into erythroid lineage with n-butyric acid and Ara-C, respectively. THP-I (monocytic), HSB-2 (T), and KM-3 (pre-B) cells also did not emit any signals (data not shown).
RESULTS
Analysis
Analysis o f expression in fractionated human hematopoietic cells. mRNA expression was analyzed by RT-PCR on 5,000 FACS-sorted human hematopoietic cells. Ethidium staining (Fig 2A) and Southern blotting (Fig 2B) showed that mRNA expression was more abundant in CD34' than in CD34-cells. Weak expression was also detected in the CD34-cell fraction. The CD33' and CD33-subfractions in both the CD34' and CD34-fractions showed no remarkable differences.
E.stahlishment of TIE MoAbs. We prepared anti-TIE MoAbs against the TIE extracellular domain. Positive hybridomas were selected by FACS, using BaF3/TlE and 3TY TIE cells as indicators. One positive clone, designated HT50, was biotinylated and used for FACS analysis. HT50 MoAb and anti-TIE polyclonal antibodies immunoprecipitated two forms of TIE protein from lysates of 3T3/TIE cells, but not from lysates of 3T3hector cells (Fig 3A) . The molecular masses of these TIE proteins were 135 and 130 kD. HT50 MoAb immunoprecipitated TIE protein also from lysates of UT-7/GM and BaF3/TIE cells, but not from HL-60 and BaF3hector cells (Fig 3B) . The molecular masses of TIE proteins in BaF3/TIE cells were different from the others (145 and 130 kD) . The TIE C-terminal synthetic peptide blocked specific binding of rabbit anti-TIE polyclonal antibody in Western blotting (Fig 3B) . In addition, a 20-fold excess molar of TIE-FLAG protein greatly reduced the amount of TIE protein immunoprecipitated with HT50 MoAb (Fig 3C) . Western blotting using antiphosphotyrosine antibody detected phosphorylation of TIE protein with larger molecular mass. but not of 130-kD TIE protein in both BaFY TIE cells (Fig 3D) and 3T3/TIE cells (data not shown). Phosphorylation of TIE protein was weak in UT-7IGM cells. which endogenously express TIE protein (data not shown). FACS analysis showed that HTS0 reacted with BaF3/TIE. HUVEC. and UT-7/GM cells, but not with BaFYvector and HL60 cells. Despite the increased mRNA level, TIE protein was not upregulated in UT-7/GM cells by PMA treatment.
Specificity of HTSO for the human TIE protein was confirmed by the finding that an excess of human TIE-lgG protein completely blocked HTS0 binding to BaF3/TIE cells. whereas mouse TIE-lgG protein did not (Fig 4) .
Detection of TIE protein 0 1 1 horw imrrow her~~ritopoietic cc4ls by FACS. Expression of TIE protein on bone marrow hematopoietic progenitor cells was determined by FACS using the anti-TIE MoAb. HTS0. At first. TIE expression was determined in comparison to known hematopoietic progenitor cell markers such as KIT, CD34, or CD38. In bone marrow mononuclear cells, about 17% of KIT' and 42% of CD34' cells were TIE'. KIT'TIE' cells were mainly CD34' (Fig SA and B) . and 37% of CD34'KIT' cells were TIE'. We performed a three-color analysis of TIE. CD34. and CD38 (Fig SC) . CD38 ~ gated cells constituted only 0.95% of total CD34' cells. and 8 I % of CD34' CD38-cells were TIE.'. TIE' cells were also characterized by lineage-specific markers. Some TIE' cells were CD33-low-positive, and most of these cells were CD34' (Fig 5D) . A significant population of B cells were TIE': 8.3% of CD19' cells ( Fig  SE) and 12.9% of CD20' cells (data not shown). However. CD3' (T) cells did not react with anti-TIE MoAb.
Progenitor ns.sny of sorted hone marrow cells. Sorted bone marrow cells were cultured in methylcellulose medium containing SCF, IL-3, and Epo. There were no significant differences in the number of colony-forming cells between the CD34' TIE' and CD34' TIE fractions. However, KIT' TIE' cells formed more granulocyte-macrophage colonies than KIT' TIE-cells (Fig 6A) . There were no significant differences in the formation of erythroid and mixed colonies between TIE' and TIE. fractions (Fig 6B) .
Assay,for LTC-IC. LTC-IC is an assay of human primitive hematopoietic precursors, and is indicated by the number of colony-forming cells after S or 7 weeks of co-culture with allogeneic stromal cells. Sorted CD34 'TIE' cells contained more LTC-ICs than CD34'TlE-cells in repeated experiments (Table I) .
DISCUSSION
A new RTK, TIE, has a unique multidomain structure consisting of immunoglobulin-like loops, EGF homology repeats. and fibronectin type 111 repeats.' This unique structure is shared by the TIE-related gene. TEK. TIE mRNA is expressed during embryonic angiogenesis" and enhanced during neovascularization.x However, TIE and TEK mRNA are expressed not only in vascular endothelial cells but also in hematopoietic cells."" Class V RTKs,'~ such as flt-I" and kdr/flk-1: ligands which are identified as placental growth facto?! and/or vascular EGF,.'7.2X are also expressed in endothelial and hematopoietic cells.
Here. we established MoAbs against the extracellular domain of TIE and analyzed expression of TIE in hematopoietic cells. Two forms of TIE proteins were similarly immunoprecipitated from lysates of 3T3/TIE cells with HTSO MoAb, mouse antiserum against the entire extracellular domain of TIE. and rabbit antiserum against the TIE C-terminus. These two proteins were also detected in BaF3/TIE cells and a human hematopoietic cell line. UT-7IGM. but not in 4, and 6) . with a rabbit anti-TIE polyclonal antibody against TIE C-terminus (lanes 1 and 21, a mouse antiserum against the entire extracellular domain of TIE (lanes 3 and 4) . or the mouse MoAb, HT50 (lanes 5 and 6). Immunoprecipitates were separated by SDS-PAGE with 7.5% polyacrylamide under reducing conditions, transferred, and then probed with a rabbit polyclonal antibody. HL-60 and BaF3hector cells. In the experiments of immunoprecipitation and FACS analysis, binding of HT50 MoAb was specifically blocked by the extracellular portion of human TIE. These findings suggest that HT50 specifically recognizes human TIE extracellular domain. Phosphorylation of TIE protein in BaF3TTIE and 3T3/TIE cells may be due to overexpression of TIE. Overexpression of TIE may induce receptor oligomerization and activation to a certain extent. On the other hand, the failure of autophosphorylation of 130-kD TIE protein suggests that this protein is conformationally inactive, and may be the immature cytoplasmic protein.
Northern blots revealed that undifferentiated hematopoietic cell lines with myeloid and megakaryocytic features expressed TIE mRNA. When megakaryocytic differentiation was induced in CMK, UT-7, and K562 cells by addition of PMA, TIE mRNA expression was increased (Fig  1) . However, TIE expression was not upregulated during erythroid differentiation of UT-7 and K562 cells. Armstrong et a12' have also reported that megakaryocytic cell lines express TIE mRNA. These findings suggest TIE involvement in megakaryocytopoiesis. However, we failed to detect TIE protein on cultured bone marrow cells in the presence of thrombopoietin by immunohistochemistry. Moreover, we could not immunoprecipitate TIE protein from platelet lysates. Further studies should be performed to clarify the expression of TIE in megakaryocytes.
RT-PCR of bone marrow cells showed that TIE was mainly expressed in CD34' progenitor cells, and FACS anal- ( -) or mouse (- ---1 TIE-lgG protein. . . . . . colony-forming cells than TIE-cells; the KIT+TIE+ fraction contained even more colony-forming cells than KIT+TIE-cells. Moreover, in CD34+ cells, TIE' cells contained more LTC-ICs than TIE-cells. Taken together, it is likely that primitive hematopoietic stem cells express TIE. On the other hand, the CD34-TIE+ population was positive for CD19 and CD20. Our preliminary data showed that murine TIE is also expressed in B220' cells (pre-B cells to mature B cells). Thus, TIE may play an important role also in the proliferation and differentiation of B cells.
Our data established TIE expression on hematopoietic prothan in committed progenitor cells. These phenotypic characteristics were consistent with the progenitor assay of sorted cells. TIE+ cells contained more granulocyte-macrophage genitor cells, especially the most primitive hematopoietic stem cells. The expression of TIE on stem cells is comparable to that of KIT and FLK-2. Although these two signal- transduction pathways are important in early hematopoiesis, interactions between stem and stromal cells, as do the ligands the null mutation of these molecules does not disrupt stemof KIT and FLK-2. Cloning the TIE ligand will show a new cell function completely?33o Other systems must be involved aspect of early hematopoiesis. in early hematopoiesis. TIE may be a novel RTK that funcHematopoietic and vascular endothelial cells are develtions in stem cells. Although the ligand has not been identioped from the common precursor cells, hemangioblasts, fied, we assume that it is expressed on stromal cells as a which are derived from the ventral mesoderm. It is of interest membrane-bound ligand and that it functions in cell-to-cell that TIE is expressed both in endothelial cells and hemato- poietic stem cells, since it may reflect the same origin of these two cell lineages. Thus, TIE expression may become a good marker for analyzing development of the endothelialhematopoietic system.
